
70% of clinical trials exclude patients with comorbidities, even though 70% of real-world patients have multiple conditions. Our CEO @BrighamHyde explores how AI-driven real-world evidence helps P&T committees build a precision formulary: pharmabusinessoutlook.com/bu… #healthcareAI











